Texas A&M Needs 500 First Responders for COVID-19 Vaccine Study

Texas A&M (TAMU) researchers stated on October 3, 2020, they are looking into an old vaccine's potential to help prevent reduce the COVID-19 pandemic in Texas. In addition to medical professionals participating in the ongoing phase 4 study of the BCG vaccine, first responders such as firefighters and police officers can now see if they are eligible for the study.

These researchers are still able to accept around 500 more individuals to participate who can visit this TAMU website for more information.

Jeffrey Cirillo, Director of A&M’s Center for Airborne Pathogen Research and Tuberculosis Imaging, said in an article 'this vaccine has the potential to be used almost immediately because it’s already FDA approved.'